Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Patient-centered outcomes of a value-based insurance design program for patients with diabetes.

Elliott DJ, Robinson EJ, Anthony KB, Stillman PL.

Popul Health Manag. 2013 Apr;16(2):99-106. doi: 10.1089/pop.2012.0031. Epub 2013 Feb 13.

PMID:
23405873
2.

The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.

Musich S, Wang S, Hawkins K.

Popul Health Manag. 2015 Jun;18(3):151-8. doi: 10.1089/pop.2014.0081. Epub 2014 Sep 23.

PMID:
25247449
3.

Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.

Maciejewski ML, Wansink D, Lindquist JH, Parker JC, Farley JF.

Health Aff (Millwood). 2014 Feb;33(2):300-8. doi: 10.1377/hlthaff.2013.0260.

4.

Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.

Peaslee A, Wickizer M, Olson J, Topp R.

J Manag Care Spec Pharm. 2016 Nov;22(11):1303-1309.

5.

The effect of a large regional health plan's value-based insurance design program on statin use.

Frank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, Chernew ME.

Med Care. 2012 Nov;50(11):934-9. doi: 10.1097/MLR.0b013e31826c8630.

PMID:
23047782
6.

Medication adherence changes following value-based insurance design.

Farley JF, Wansink D, Lindquist JH, Parker JC, Maciejewski ML.

Am J Manag Care. 2012 May;18(5):265-74.

7.

Five features of value-based insurance design plans were associated with higher rates of medication adherence.

Choudhry NK, Fischer MA, Smith BF, Brill G, Girdish C, Matlin OS, Brennan TA, Avorn J, Shrank WH.

Health Aff (Millwood). 2014 Mar;33(3):493-501. doi: 10.1377/hlthaff.2013.0060. Epub 2014 Feb 12.

8.

Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.

McAdam-Marx C, Bellows BK, Unni S, Wygant G, Mukherjee J, Ye X, Brixner DI.

J Manag Care Spec Pharm. 2014 Jul;20(7):691-700.

9.
10.

Impact of a patient-centered pharmacy program and intervention in a high-risk group.

Moore JM, Shartle D, Faudskar L, Matlin OS, Brennan TA.

J Manag Care Pharm. 2013 Apr;19(3):228-36.

11.

Clinical and economic outcomes of the Cincinnati Pharmacy Coaching Program for diabetes and hypertension.

Wertz D, Hou L, DeVries A, Dupclay L Jr, McGowan F, Malinowski B, Cziraky MJ.

Manag Care. 2012 Mar;21(3):44-54.

12.

Evaluation of value-based insurance design with a large retail employer.

Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA.

Am J Manag Care. 2011 Oct;17(10):682-90.

PMID:
22106461
13.

Clinical outcomes and incremental costs from a medication adherence pilot intervention targeting low-income patients with diabetes at risk of cost-related medication nonadherence.

Ryan JG, Fedders M, Jennings T, Vittoria I, Yanes M.

Clin Ther. 2014 Dec 1;36(12):1991-2002. doi: 10.1016/j.clinthera.2014.09.001. Epub 2014 Oct 2.

PMID:
25282579
14.
15.

Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).

Duru OK, Turk N, Ettner SL, Neugebauer R, Moin T, Li J, Kimbro L, Chan C, Luchs RH, Keckhafer AM, Kirvan A, Ho S, Mangione CM.

J Gen Intern Med. 2015 Nov;30(11):1645-50. doi: 10.1007/s11606-015-3284-8. Epub 2015 May 6.

16.

Connecticut's Value-Based Insurance Plan Increased The Use Of Targeted Services And Medication Adherence.

Hirth RA, Cliff EQ, Gibson TB, McKellar MR, Fendrick AM.

Health Aff (Millwood). 2016 Apr;35(4):637-46. doi: 10.1377/hlthaff.2015.1371.

PMID:
27044964
17.

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.

Clin Ther. 2003 Nov;25(11):2958-71.

PMID:
14693318
18.

A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial.

Spaulding A, Fendrick AM, Herman WH, Stevenson JG, Smith DG, Chernew ME, Parsons DM, Bruhnsen K, Rosen AB.

Implement Sci. 2009 Apr 7;4:19. doi: 10.1186/1748-5908-4-19.

19.

The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.

McAdam-Marx C, Dahal A, Jennings B, Singhal M, Gunning K.

J Manag Care Spec Pharm. 2015 Jun;21(6):452-68.

20.

Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.

Tschida S, Aslam S, Khan TT, Sahli B, Shrank WH, Lal LS.

J Manag Care Pharm. 2013 Jan-Feb;19(1):26-41.

Supplemental Content

Support Center